Predicting EGFR mutation status in lung adenocarcinoma: development and validation of a computed tomography-based radiomics signature

Patients with epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma can benefit from targeted therapy. However, noninvasively determination of EGFR mutation status before targeted therapy remains a challenge. This study constructed a nomogram based on a combination of radiomics fe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Cancer Res
Autores principales: Zhang, Guojin, Cao, Yuntai, Zhang, Jing, Ren, Jialiang, Zhao, Zhiyong, Zhang, Xiaodi, Li, Shenglin, Deng, Liangna, Zhou, Junlin
Formato: Artigo
Lenguaje:Inglês
Publicado: e-Century Publishing Corporation 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7868761/
https://ncbi.nlm.nih.gov/pubmed/33575086
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares